Dr. Suman Jayadev
Claim this profileUniversity of Washington
Studies Alzheimer's Disease
Studies Dementia
5 reported clinical trials
9 drugs studied
Area of expertise
1Alzheimer's Disease
APP positive
PSEN1 positive
PSEN2 positive
2Dementia
APP positive
PSEN1 positive
PSEN2 positive
Affiliated Hospitals
University Of Washington
University Of Washington Department Of Neurology
Clinical Trials Suman Jayadev is currently running
PTC518
for Huntington's Disease
This trial is testing a new drug called PTC518 to see if it is safe and how it affects people with Huntington's Disease. The goal is to find out if PTC518 can help manage symptoms or slow down the disease.
Recruiting0 awards Phase 23 criteria
Lecanemab
for Alzheimer's Disease
This is an open label study to treat dominantly inherited Alzheimer's disease (DIAD) mutation carrier participants from the DIAN-TU-001 gantenerumab Open Label Extension (OLE) period with lecanemab to determine the effects of amyloid removal on age of onset and clinical progression compared to external controls, if amyloid plaque as measured by amyloid PET can be fully removed in DIAD, and the effects of amyloid removal on biomarkers of disease progression.
Recruiting2 awards Phase 3
More about Suman Jayadev
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Suman Jayadev has experience with
- Gantenerumab
- E2814
- Lecanemab
- Solanezumab
- PTC518
- Placebo
Breakdown of trials Suman Jayadev has run
Alzheimer's Disease
Dementia
Huntington's Disease
Alzheimer's
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Suman Jayadev specialize in?
Suman Jayadev focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved APP positive patients, or patients who are PSEN1 positive.
Is Suman Jayadev currently recruiting for clinical trials?
Yes, Suman Jayadev is currently recruiting for 3 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Suman Jayadev has studied deeply?
Yes, Suman Jayadev has studied treatments such as Gantenerumab, E2814, Lecanemab.
What is the best way to schedule an appointment with Suman Jayadev?
Apply for one of the trials that Suman Jayadev is conducting.
What is the office address of Suman Jayadev?
The office of Suman Jayadev is located at: University of Washington, Seattle, Washington 98195 United States. This is the address for their practice at the University of Washington.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.